Michael G. Grey

Insider Reports History

Entity
Individual
Location
C/O Sgx Pharmaceuticals, Inc., 10505 Roselle Street, San Diego, California
Signature
/s/ Judit Ryvkin, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Michael G. Grey:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Mirum Pharmaceuticals, Inc. Director Common Stock 289K $8.11M $28.04 Sep 13, 2023 By The Grey Family Trust dated November 12,1999
Mirum Pharmaceuticals, Inc. Director Common Stock 93.8K $2.63M $28.04 Sep 13, 2023 By The Grey 2018 Irrevocable Children's Trust
Reneo Pharmaceuticals, Inc. Executive Chairman, Director Common Stock 134K $841K $6.28 Jul 26, 2023 By Trust
Mirum Pharmaceuticals, Inc. Director Deferred Stock Units 5.7K $146K $25.68 Jun 5, 2024 Direct
SPRUCE BIOSCIENCES, INC. Executive Chairman, Director Stock Option (Right to Buy) 30K May 22, 2024 Direct
Mirum Pharmaceuticals, Inc. Director Stock Option (right to buy) 8.78K Jun 5, 2024 Direct
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 By Davy Trust
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 By Family Trust
Horizon Therapeutics Public Ltd Co Director Ordinary Shares 0 $116.50 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co Director Restricted Stock Units 0 Oct 6, 2023 Direct
Horizon Therapeutics Public Ltd Co Director Stock Option (Right to Buy) 0 Oct 6, 2023 Direct
Mirum Pharmaceuticals, Inc. Director Common Stock 0 $28.04 Sep 14, 2023 Direct
Reneo Pharmaceuticals, Inc. Executive Chairman, Director Common Stock 0 $6.28 Jul 26, 2023 Direct

Insider Reports Filed by Michael G. Grey

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MIRM Mirum Pharmaceuticals, Inc. Jun 5, 2024 2 $0 4 Jun 7, 2024 Director
SPRB SPRUCE BIOSCIENCES, INC. May 22, 2024 1 $0 4 May 24, 2024 Executive Chairman, Director
HZNP Horizon Therapeutics Public Ltd Co Oct 6, 2023 8 -$11.3M 4 Oct 6, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Sep 28, 2023 2 $319K 4 Sep 28, 2023 Director
MIRM Mirum Pharmaceuticals, Inc. Sep 13, 2023 6 -$425K 4 Sep 14, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Jul 27, 2023 1 $0 4 Jul 28, 2023 Director
RPHM Reneo Pharmaceuticals, Inc. Jul 26, 2023 1 $0 4 Jul 27, 2023 Executive Chairman, Director
MIRM Mirum Pharmaceuticals, Inc. Jun 12, 2023 1 $0 4 Jun 14, 2023 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 8, 2023 3 -$381K 4 Jun 9, 2023 Director
RPHM Reneo Pharmaceuticals, Inc. Jun 6, 2023 1 $0 4 Jun 8, 2023 Executive Chairman, Director
SPRB SPRUCE BIOSCIENCES, INC. May 25, 2023 1 $0 4 May 26, 2023 Executive Chairman, Director
MIRM Mirum Pharmaceuticals, Inc. May 3, 2023 3 -$366K 4 May 4, 2023 Director
HZNP Horizon Therapeutics Public Ltd Co Apr 28, 2023 2 $0 4 May 2, 2023 Director
RPHM Reneo Pharmaceuticals, Inc. Aug 31, 2022 2 $98.5K 4 Sep 2, 2022 Executive Chairman, Director
MIRM Mirum Pharmaceuticals, Inc. Jun 2, 2022 1 $0 4 Jun 6, 2022 Director
RPHM Reneo Pharmaceuticals, Inc. Jun 1, 2022 1 $0 4 Jun 3, 2022 Executive Chairman, Director
SPRB SPRUCE BIOSCIENCES, INC. May 25, 2022 1 $0 4 May 27, 2022 Executive Chairman, Director
HZNP Horizon Therapeutics Public Ltd Co Apr 28, 2022 4 -$112K 4 May 2, 2022 Director
SPRB SPRUCE BIOSCIENCES, INC. Dec 16, 2021 1 $0 4 Dec 20, 2021 Executive Chairman, Director
HZNP Horizon Therapeutics Public Ltd Co Jul 22, 2021 4 -$488K 4 Jul 23, 2021 Director
MIRM Mirum Pharmaceuticals, Inc. Jun 4, 2021 1 $0 4 Jun 8, 2021 Director
SPRB SPRUCE BIOSCIENCES, INC. May 20, 2021 1 $0 4 May 21, 2021 Executive Chairman, Director